Neurogenetics

Neurogenetics investigates how genetic variation and gene expression shape the development, function and pathology of the nervous system. This discipline spans the identification of disease-causing mutations, the dissection of gene–environment interactions and the deployment of model organisms—from yeast and nematode worms to flies, fish and mice—to probe molecular pathways underlying neuronal differentiation, synaptic plasticity and circuit dynamics. In parallel, human genetics and induced pluripotent stem cell (iPSC) models have revealed how risk variants in genes such as APOE, GBA1 and TOR1A predispose individuals to late-onset neurodegenerative conditions, including Alzheimer’s disease, Parkinson’s disease and dystonia. Recent advances in genome editing, single-cell transcriptomics, high-resolution imaging and proteomics now allow investigators to link genotype to cell-specific phenotypes, highlighting convergent mechanisms—such as lysosomal clearance, mitochondrial homeostasis, R-loop resolution and lipid metabolism—that may serve as therapeutic targets across distinct disorders.

Research from Nature Portfolio

Recent studies have illuminated a critical role for the RNA/DNA helicase senataxin in neuronal genome maintenance. When double-strand breaks arise in actively transcribed genes, senataxin is recruited to unwind RNA:DNA hybrids and facilitate RAD51-mediated homologous recombination, thereby preventing illegitimate end-joining and chromosomal translocations. Complementary work has identified the deubiquitinase USP11 as a key regulator of senataxin proteostasis: USP11 removes K48-linked ubiquitin chains from senataxin, stabilising the helicase, enhancing R-loop clearance and preserving replication fork progression under stress. Together, these findings define how senataxin activity and ubiquitination dynamics intersect with DNA damage signalling in neurons and provide mechanistic insights into ataxia and motor neuron disease linked to SETX mutations.

Research from all publishers

A mouse model of DYT1 dystonia generated by conditional deletion of TOR1A in spinal motor and sensory neurons reveals that aberrant spinal circuitry can induce early-onset, generalised dystonic postures, co-contractions and impaired monosynaptic reflexes, shifting the focus of dystonia pathogenesis to the spinal cord rather than solely the basal ganglia. In Parkinson’s disease, proteomic analyses of iPSC-derived neurons and midbrain organoids carrying GBA1 mutations have uncovered internal mitochondrial targeting sequences in glucocerebrosidase (GCase). Once imported, GCase preserves mitochondrial complex I integrity, supports energy metabolism and interacts with mitochondrial quality-control chaperones; GBA1 mutations disrupt these functions, linking defective lysosomal enzyme activity to mitochondrial failure. In parallel, genome-wide screens in yeast, Caenorhabditis elegans and Drosophila have identified riboflavin kinase (FMN1) as a modifier of amyloid-β toxicity: its product, flavin mononucleotide (FMN), enhances NADH/NAD+ and NADPH/NADP+ ratios, bolsters resistance to oxidative stress and mitigates proteotoxicity of amyloid-β, expanded polyglutamine tracts and α-synuclein, demonstrating the power of simple eukaryotes to uncover metabolic neuroprotective pathways.

Neurogenetics publication trend

The graph below shows the total number of articles in neurogenetics across all publications each year (not limited to Nature Index journals).

Technical terms

R-loop: A three-stranded nucleic acid structure comprising an RNA:DNA hybrid and displaced single-stranded DNA formed when transcription outpaces RNA processing.

Homologous recombination: An error-free DNA repair pathway that uses an undamaged homologous duplex as a template to restore broken DNA strands.

Monosynaptic reflex arc: A spinal circuit in which a primary sensory neuron directly synapses onto a motor neuron, mediating rapid protective reflexes.

Proteostasis: The network of cellular pathways that govern protein folding, quality control, trafficking and degradation to maintain a functional proteome.

iPSC-derived neurons: Neurons generated in vitro from reprogrammed patient cells, retaining the individual’s genetic background for disease modelling.

Flavin mononucleotide (FMN): A redox cofactor produced by riboflavin kinase that participates in electron transfer and antioxidant defence mechanisms.

References

1. Introduction to Neurogenetics.
2. Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations. Nature Communications (2018).
3. USP11 controls R-loops by regulating senataxin proteostasis. Nature Communications (2021).
4. Pathophysiology of Dyt1-Tor1a dystonia in mice is mediated by spinal neural circuit dysfunction. Science Translational Medicine (2023).
5. Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism. Nature Communications (2023).
6. FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism. Nature Communications (2020).